Health & Biotech

Sheba ARC — the innovation arm of Sheba Medical Center. Founded 2019 by Prof. Eyal Zimlichman. 100+ startups, 3 unicorns, $1B+ invested, 160 FTEs — th…

Israel has 1,800 life-sciences companies and almost no blockbuster drugs. That's not a weakness. That's the strategy — devices, AI health, Weizmann li…

Leumit covers ~750,000 Israelis — the smallest of the four HMOs, and roughly the size of the population of San Francisco. Often discounted. Frequently…

He sold his family's pharma company Agis to Perrigo in 2005 for $818M and turned the proceeds into one of the most active private investment vehicles…

Israel's biotech decade is no longer a frontier story — it's a category. $1.2 billion a year in health-tech funding, AI-native drug discovery platform…

Meuhedet covers ~1.3 million Israelis — ~14% of the country — and indexes heavily toward the religious, Haredi, and large-family communities growing f…

Israel's four HMOs control more than $25 billion in annual healthcare procurement. Their decisions on AI, pharma, diagnostics, and digital health shap…

Israel's grimmest input — a long history of war injury — has become a real engine of medical innovation. It is an uncomfortable fact, and an honest ac…

Israel's most distinctive contribution to medicine is not a drug or a device. It is a model: the hospital itself turned into a co-development engine t…